Radix isatidis polysaccharides inhibit influenza a virus and influenza a virus-induced inflammation via suppression of host TLR3 signaling in vitro

Molecules

Volumn 22, Issue 1, 2017, Pages

  Li, Zhengtu ^a   Li, Li ^b   Zhou, Hongxia ^a   Zeng, Lijuan ^a   Chen, Tingting ^a   Chen, Qiaolian ^a   Zhou, Beixian ^a   Wang, Yutao ^a   Chen, Qiaoyan ^c   Hu, Ping ^d   Yang, Zifeng ^a,e  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b Department of Obstetrics and Gynecology   (China)

^c GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

^d EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^e MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

Author keywords

Anti inflammatory; Antiviral; Polysaccharides; Radix isatidis; TLR 3

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT; BANLANGEN; CCL5 PROTEIN, HUMAN; CXCL9 CHEMOKINE; CXCL9 PROTEIN, HUMAN; HERBACEOUS AGENT; IL10 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; INTERLEUKIN 10; INTERLEUKIN 6; POLYSACCHARIDE; RANTES; TLR3 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 3;

ANIMAL; ANTAGONISTS AND INHIBITORS; BRONCHUS; CELL LINE; CELL SURVIVAL; CHEMISTRY; CHICKEN; CYTOLOGY; DOG; DRUG EFFECTS; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA A VIRUS (H9N2); ISOLATION AND PURIFICATION; MDCK CELL LINE; SIGNAL TRANSDUCTION; VIROLOGY; ZYGOTE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIVIRAL AGENTS; BRONCHI; CELL LINE; CELL SURVIVAL; CHEMOKINE CCL5; CHEMOKINE CXCL9; CHICKENS; DOGS; DRUGS, CHINESE HERBAL; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA A VIRUS, H9N2 SUBTYPE; INTERLEUKIN-10; INTERLEUKIN-6; MADIN DARBY CANINE KIDNEY CELLS; POLYSACCHARIDES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 3; ZYGOTE;

EID: 85009775707     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules22010116     Document Type: Article

References (36)

1. Dienz, O.; Rud, J.G.; Eaton, S.M.; Lanthier, P.A.; Burg, E.; Drew, A.; Bunn, J.; Suratt, B.T.; Haynes, L.; Rincon, M. Essential role of IL-6 in protection against H1N1 influenza virus by promoting neutrophil survival in the lung. Mucosal Immunol. 2012, 5, 258-266. [CrossRef] [PubMed]
2. Zhang,W.;Wan, J.; Qian, K.; Liu, X.; Xiao, Z.; Sun, J.; Zeng, Z.;Wang, Q.; Zhang, J.; Jiang, G.; et al. Clinical characteristics of human infection with a novel avian-origin influenza a(H10N8) virus. Chin. Med. J. (Engl.) 2014, 127, 3238-3242. [PubMed]
3. Yang, Z.F.; Mok, C.K.; Peiris, J.S.; Zhong, N.S. Human infection with a novel avian influenza a(H5N6) virus. N. Engl. J. Med. 2015, 373, 487-489. [CrossRef] [PubMed]
4. Yang, Z.F.; Mok, C.K.; Liu, X.Q.; Li, X.B.; He, J.F.; Guan, W.D.; Xu, Y.H.; Pan, W.Q.; Chen, L.Y.; Lin, Y.P.; et al. Clinical, virological and immunological features from patients infected with re-emergent avian-origin human H7N9 influenza disease of varying severity in guangdong province. PLoS ONE 2015, 10, e0117846. [CrossRef] [PubMed]
5. Hampson, A.W. Vaccines for pandemic influenza. The history of our current vaccines, their limitations and the requirements to deal with a pandemic threat. Ann. Acad. Med. Singap. 2008, 37, 510-517. [PubMed]
6. De Clercq, E. Antivirals and antiviral strategies. Nat. Rev. Microbiol 2004, 2, 704-720. [CrossRef] [PubMed]
7. Crunkhorn, S. Infectious diseases: Novel agents fight flu infection. Nat. Rev. Drug Discov. 2013, 12, 345. [CrossRef] [PubMed]
8. Chen, J.; Duan, M.; Zhao, Y.; Ling, F.; Xiao, K.; Li, Q.; Li, B.; Lu, C.; Qi, W.; Zeng, Z.; et al. Saikosaponin a inhibits influenza a virus replication and lung immunopathology. Oncotarget 2015, 6, 42541-42556. [PubMed]
9. Zhou, J.; Wang, D.; Gao, R.; Zhao, B.; Song, J.; Qi, X.; Zhang, Y.; Shi, Y.; Yang, L.; Zhu,W.; et al. Biological features of novel avian influenza a (H7N9) virus. Nature 2013, 499, 500-503. [CrossRef] [PubMed]
10. De Jong, M.D.; Simmons, C.P.; Thanh, T.T.; Hien, V.M.; Smith, G.J.; Chau, T.N.; Hoang, D.M.; Chau, N.V.; Khanh, T.H.; Dong, V.C.; et al. Fatal outcome of human influenza a (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 2006, 12, 1203-1207. [CrossRef] [PubMed]
11. Herold, S.; Steinmueller, M.; vonWulffen, W.; Cakarova, L.; Pinto, R.; Pleschka, S.; Mack, M.; Kuziel,W.A.; Corazza, N.; Brunner, T.; et al. Lung epithelial apoptosis in influenza virus pneumonia: The role of macrophage-expressed tnf-related apoptosis-inducing ligand. J. Exp. Med. 2008, 205, 3065-3077. [CrossRef] [PubMed]
12. Baillie, J.K.; Digard, P. Influenza-Time to target the host? N. Engl. J. Med. 2013, 369, 191-193. [PubMed]
13. Ramos, I.; Fernandez-Sesma, A. Modulating the innate immune response to influenza a virus: Potential therapeutic use of anti-inflammatory drugs. Front. Immunol. 2015, 6, 361. [CrossRef] [PubMed]
14. Yang, Z.; Wang, Y.; Zheng, Z.; Zhao, S.; Zhao, J.; Lin, Q.; Li, C.; Zhu, Q.; Zhong, N. Antiviral activity of isatis indigotica root-derived clemastanin b against human and avian influenza a and b viruses in vitro. Int. J. Mol. Med. 2013, 31, 867-873. [PubMed]
15. Zuo, L.; Li, J.B.; Xu, J.; Yang, J.Z.; Zhang, D.M.; Tong, Y.L. Studies on chemical constituents in root of isatis indigotica. China J. Chin. Mater. Med. 2007, 32, 688-691.
16. Li, L.; Qiao, C.Z.; Li, X.L.; Dong, T.Y. Study of quality control on herbal drugs and preparations of daqingye and banlangen. Yao Xue Xue Bao 1993, 28, 229-233. [PubMed]
17. Mak, N.K.; Leung, C.Y.; Wei, X.Y.; Shen, X.L.; Wong, R.N.; Leung, K.N.; Fung, M.C. Inhibition of rantes expression by indirubin in influenza virus-infected human bronchial epithelial cells. Biochem. Pharmacol. 2004, 67, 167-174. [CrossRef] [PubMed]
18. Mok, C.K.; Kang, S.S.; Chan, R.W.; Yue, P.Y.; Mak, N.K.; Poon, L.L.; Wong, R.N.; Peiris, J.S.; Chan, M.C. Anti-inflammatory and antiviral effects of indirubin derivatives in influenza a (H5N1) virus infected primary human peripheral blood-derived macrophages and alveolar epithelial cells. Antivir. Res. 2014, 106, 95-104. [CrossRef] [PubMed]
19. Li, J.; Zhou, B.; Li, C.; Chen, Q.; Wang, Y.; Li, Z.; Chen, T.; Yang, C.; Jiang, Z.; Zhong, N.; et al. Lariciresinol-4-O-beta-D-glucopyranoside from the root of isatis indigotica inhibits influenza a virus-induced pro-inflammatory response. J. Ethnopharmacol. 2015, 174, 379-386. [CrossRef] [PubMed]
20. Shin, E.K.; Kim, D.H.; Lim, H.; Shin, H.K.; Kim, J.K. The anti-inflammatory effects of a methanolic extract from Radix isatidis in murine macrophages and mice. Inflammation 2010, 33, 110-118. [CrossRef] [PubMed]
21. Yang, Z.;Wang, Y.; Zhong, S.; Zhao, S.; Zeng, X.; Mo, Z.; Qin, S.; Guan,W.; Li, C.; Zhong, N. In vitro inhibition of influenza virus infection by a crude extract from isatis indigotica root resulting in the prevention of viral attachment. Mol. Med. Rep. 2012, 5, 793-799. [PubMed]
22. Guo, H.X.-L.;Wang, Y.; Yang, Z.;Wang, Y.; Li, Z.; Hu, P. System isolation and purification of Radix isatidis polysaccharides and determination of their compositions. Chin. Tradit. Herb. Drugs 2016, 47, 1508-1514.
23. Liu, H.; Zhang, W.; Dong, S.; Song, L.; Zhao, S.; Wu, C.; Wang, X.; Liu, F.; Xie, J.; Wang, J.; et al. Protective effects of sea buckthorn polysaccharide extracts against lps/d-galn-induced acute liver failure in mice via suppressing tlr4-nf-kappab signaling. J. Ethnopharmacol. 2015, 176, 69-78. [CrossRef] [PubMed]
24. Yang, Z.F.;Wang, Y.T.; Qin, S.; Zhao, S.S.; Zhao, Y.S.; Lin, Q.; Guan,W.D.; Huang, Q.D.; Mo, Z.Y.; Li, C.Y.; et al. The effects of a hot water soluble extract (S-03) isolated from isatis indigotica root on inf luenza a and b viruses in vitro. Chin. J. Virol. 2011, 27, 218-223. [CrossRef] [PubMed]
25. Kido, H.; Okumura, Y.; Yamada, H.; Le, T.Q.; Yano, M. Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents. Curr. Pharm. Des. 2007, 13, 405-414. [CrossRef] [PubMed]
26. Du, Z.; Liu, H.; Zhang, Z.; Li, P. Antioxidant and anti-inflammatory activities of Radix isatidis polysaccharide in murine alveolar macrophages. Int. J. Biol. Macromol. 2013, 58, 329-335. [CrossRef] [PubMed]
27. Iwasaki, A.; Pillai, P.S. Innate immunity to influenza virus infection. Nat. Rev. Immunol. 2014, 14, 315-328. [CrossRef] [PubMed]
28. Teijaro, J.R.;Walsh, K.B.; Rice, S.; Rosen, H.; Oldstone, M.B. Mapping the innate signaling cascade essential for cytokine storm during influenza virus infection. Proc. Natl. Acad. Sci. USA 2014, 111, 3799-3804. [CrossRef] [PubMed]
29. Lam, W.Y.; Yeung, A.C.; Chan, P.K. Apoptosis, cytokine and chemokine induction by non-structural 1 (NS1) proteins encoded by different influenza subtypes. Virol. J. 2011, 8, 554. [CrossRef] [PubMed]
30. Chi, Y.; Zhu, Y.;Wen, T.; Cui, L.; Ge, Y.; Jiao, Y.;Wu, T.; Ge, A.; Ji, H.; Xu, K.; et al. Cytokine and chemokine levels in patients infected with the novel avian influenza a (H7N9) virus in china. J. Infect. Dis. 2013, 208, 1962-1967. [CrossRef] [PubMed]
31. Lee, N.; Wong, C.K.; Chan, P.K.; Chan, M.C.; Wong, R.Y.; Lun, S.W.; Ngai, K.L.; Lui, G.C.; Wong, B.C.; Lee, S.K.; et al. Cytokine response patterns in severe pandemic 2009 h1n1 and seasonal influenza among hospitalized adults. PLoS ONE 2011, 6, e26050. [CrossRef] [PubMed]
32. Le Goffic, R.; Balloy, V.; Lagranderie, M.; Alexopoulou, L.; Escriou, N.; Flavell, R.; Chignard, M.; Si-Tahar, M. Detrimental contribution of the toll-like receptor (TLR)3 to influenza a virus-induced acute pneumonia. PLoS Pathog. 2006, 2, e53. [CrossRef] [PubMed]
33. Wang, Q.; Miller, D.J.; Bowman, E.R.; Nagarkar, D.R.; Schneider, D.; Zhao, Y.; Linn, M.J.; Goldsmith, A.M.; Bentley, J.K.; Sajjan, U.S.; et al. MDA5 and TLR3 initiate pro-inflammatory signaling pathways leading to rhinovirus-induced airways inflammation and hyperresponsiveness. PLoS Pathog. 2011, 7, e1002070. [CrossRef] [PubMed]
34. Pang, I.K.; Pillai, P.S.; Iwasaki, A. Efficient influenza a virus replication in the respiratory tract requires signals from tlr7 and rig-i. Proc. Natl. Acad. Sci. USA 2013, 110, 13910-13915. [CrossRef] [PubMed]
35. Wang, C.H.; Zhong, Y.; Zhang, Y.; Liu, J.P.; Wang, Y.F.; Jia, W.N.; Wang, G.C.; Li, Z.; Zhu, Y.; Gao, X.M. A network analysis of the chinese medicine lianhua-qingwen formula to identify its main effective components. Mol. Biosyst. 2016, 12, 606-613. [CrossRef] [PubMed]
36. Muench, L.J.R.A.H. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 1938, 27, 493-497.